WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Technology Software Products Wednesday, October 18, 2017 
Add Press Release News | News Feeds Feeds | Email This News Email

Swift Launches Accel-Amplicon(TM) Custom NGS Panels, Accelerating Variant Discovery In Challenging Biological Samples
Friday, October 13, 2017

Genialis/Swift partnership delivers a complete targeted sequencing solution with intuitive analysis software

ANN ARBOR, Mich., Oct. 13, 2017 /PRNewswire/ -- Swift Biosciences, a leading provider of innovative library prep solutions for next-generation sequencing (NGS), today announced the launch of its Accel-Amplicon(TM) Custom NGS Panels. These new panels offer a targeted DNA sequencing product that enables clinical researchers to rapidly design highly focused panels to discover, validate and screen disease genes and their variants.

With the quickest workflow, Swift's Accel-Amplicon(TM) Custom NGS Panel is a powerful solution to discover and assess clinically-relevant mutations across targeted genes using multiplexed amplicon sequencing. The panel is platform agnostic and addresses many applications such as fine mapping, variant discovery and screening, post GWAS replication, drug target discovery, clinical trial management and monitoring therapeutic efficacy.

"Our Accel-Amplicon Custom NGS Panels offer a breakthrough for translational researchers to interrogate variants within sample types that were impractical until now," said Candia Brown, Swift's Vice President of Global Marketing. "We've taken everything we've learned from our pre-designed panels and collaborative partnerships to deliver a transformative workflow that helps any laboratory implement targeted sequencing and rapidly uncover new biological insights into complex diseases."

Key features and benefits of the Accel-Amplicon Custom NGS Panel include:

    --  Supports the widest range of input sample types including fresh and
        fresh-frozen tissue, whole blood, blood spot cards, FFPE, cell-free DNA,
        circulating tumor DNA, buccal swab, whole genome amplified DNA and
        purified DNA.
    --  Requires the least amount of sample input with only 10 nanograms
    --  Enables the fastest library prep workflow in under two hours
    --  Provides the only single-tube NGS assay with complete and comprehensive
        genomic coverage
    --  Includes fully optimized and wet-lab validated NGS assays in every
    --  Supported on either Ion Torrent or Illumina sequencing platforms

To complete this breakthrough workflow, Swift partnered with Genialis, a software solution company, to integrate alignment, trimming, QC and variant calling into one simple pipeline. The Genialis' cloud application also automates an algorithm optimized for accurate variant detection, including low frequency variants in heterogeneous samples, such as cancer. It is fast and easy to use, as it offers data visualization and annotated variants using direct links to publicly available databases such as COSMIC and NCBI.

"Targeted NGS sequencing is transforming translational research and genomic medicine by allowing researchers to rapidly and confidently screen important variants," said Rafael Rosengarten, Genialis' President and Chief Product Officer. "However, data analysis and interpretation is a long-standing bottleneck that has significantly constrained the speed and scale of these studies. This alliance with Swift Biosciences will enable us to deliver our innovative algorithms and interface to transform how researchers call, visualize and annotate variants. This will yield faster discoveries and support broader collaboration between laboratories."

The Accel-Amplicon Custom NGS Panel is now commercially available. At ASHG 2017, Swift and Genialis will debut the complete targeted sequencing workflow at a Swift educational workshop on October 19. The event, entitled "Harnessing the Power of Next-Generation Sequencing for Precision Medicine" will be held at the Hilton Orlando Hotel, Lake George Ballroom.

View original content:

SOURCE Swift Biosciences

Email This News Email | Submit To Slashdot Slashdot | Submit To Digg | Submit To | News Feeds Feeds

Nav iTrinegy INE Network Emulator Range Adds Cisco® QoS, Wireshark®-like Classification & Packet Generation | Oct 18, 2017
Nav Cambridge Pixel Supplies Radar Trackers to Enhance Target Detection at Chinese Airports | Oct 18, 2017
Nav Enterprise Metadata Management Market Worth 7.85 Billion USD by 2022 | Oct 18, 2017
Nav DataCore Announces New Versions of Software-Defined Infrastructure Products to Address the Challenges of Digital Transformation | Oct 18, 2017
Nav Docker Expands Partnership with IBM to Address Growing Demand for the Modernize Traditional Applications (MTA) Program | Oct 18, 2017
Nav New Elektrobit software enables automakers to build high-performance ECUs for connected and highly automated vehicles | Oct 18, 2017
Nav Cortex Intel Mobile App Delivers Millions in Value and Big Sustainability Gains for 277 Park Avenue, The Woolworth Building, and 110 William Street | Oct 18, 2017
Nav Global Internet of Things (IoT) Strategic Business Report 2017-2024 - A Peek into the Massive Potential and True Scale of IoT Opportunity | Oct 18, 2017
Nav Information Builders Ranks First Among Its Peers in Operational BI and Vendor Support in BARC's The BI Survey 17 | Oct 18, 2017
Nav Maximizer delivers on its vision of personalized experiences with its cloud integration platform | Oct 18, 2017

Submit News | View More News View More News